Suven Life Sciences

quarterly
yearly
ParticularsSep '24Dec '24Mar '25Jun '25Sep '25
Revenue6.613.242.692.474.70
Expenses56.2642.3646.6353.9882.01
EBITDA-48.17-37.58-42.59-50.15-75.99
EBIT-49.62-39.11-43.94-51.52-77.31
Profit Before Tax-49.64-39.12-43.94-51.52-77.31
Net Profit-49.64-39.12-43.94-51.52-77.31
Financial Ratios
Operating Profit Margin-1,874%-2,334%-2,898%-2,682%-8,260%
Net Profit Margin-1,932%-2,430%-2,989%-2,755%-8,403%
Earning Per Share (Diluted)-2.27-1.79-2.02-2.36-3.48
Dividends Per Share0.000.000.000.000.00